- Home
- ALT vs GMRE Comparison
ALT vs GMRE Comparison
Compare ALT & GMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALT
- GMRE
- Stock Information
- Founded
- ALT 1997
- GMRE 2011
- Country
- ALT United States
- GMRE United States
- Employees
- ALT N/A
- GMRE N/A
- Industry
- ALT Biotechnology: Pharmaceutical Preparations
- GMRE Real Estate Investment Trusts
- Sector
- ALT Health Care
- GMRE Real Estate
- Exchange
- ALT Nasdaq
- GMRE Nasdaq
- Market Cap
- ALT 472.3M
- GMRE 485.5M
- IPO Year
- ALT N/A
- GMRE N/A
- Fundamental
- Price
- ALT $4.55
- GMRE $7.48
- Analyst Decision
- ALT Strong Buy
- GMRE Strong Buy
- Analyst Count
- ALT 8
- GMRE 3
- Target Price
- ALT $21.00
- GMRE $10.88
- AVG Volume (30 Days)
- ALT 2.2M
- GMRE 691.8K
- Earning Date
- ALT 05-08-2025
- GMRE 05-06-2025
- Dividend Yield
- ALT N/A
- GMRE 11.43%
- EPS Growth
- ALT N/A
- GMRE N/A
- EPS
- ALT N/A
- GMRE 0.01
- Revenue
- ALT $20,000.00
- GMRE $138,760,000.00
- Revenue This Year
- ALT N/A
- GMRE $7.89
- Revenue Next Year
- ALT N/A
- GMRE $3.13
- P/E Ratio
- ALT N/A
- GMRE $637.54
- Revenue Growth
- ALT N/A
- GMRE N/A
- 52 Week Low
- ALT $3.55
- GMRE $6.75
- 52 Week High
- ALT $11.16
- GMRE $10.46
- Technical
- Relative Strength Index (RSI)
- ALT 43.21
- GMRE 40.89
- Support Level
- ALT $4.32
- GMRE $6.75
- Resistance Level
- ALT $4.75
- GMRE $7.68
- Average True Range (ATR)
- ALT 0.38
- GMRE 0.37
- MACD
- ALT 0.05
- GMRE -0.05
- Stochastic Oscillator
- ALT 63.22
- GMRE 34.27
About ALT Altimmune Inc.
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.
About GMRE Global Medical REIT Inc.
Global Medical REIT Inc is engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.